Career Opportunity: Clinical Research Coordinator at Tata Memorial Hospital (TMC), Mumbai
Pharm'Up 
The Tata Memorial Centre (TMC), a premier autonomous institution under the Department of Atomic Energy, Government of India, has announced a walk-in interview for the position of Clinical Research Coordinator. This recruitment is for specialized pediatric oncology research trials focusing on Refractory Hodgkin Lymphoma and High-Risk Neuroblastoma.
Vacancy Details
The selected candidates will be involved in two major phase II clinical trials involving advanced immunotherapies (Nivolumab and Naxitamab).
- Post Name: Clinical Research Coordinator
- Number of Posts: 02
- Remuneration: ₹29,000/- per month
- Tenure: Initially for a period of six months (extendable based on project requirements).
- Age Limit: Up to 35 years.
Eligibility Criteria
To be eligible for this role, candidates must meet the following mandatory academic and professional requirements:
Educational Qualification:
- B.Pharm or B.Sc / Graduate in Life Sciences.
- P.G. Diploma in Clinical Research (Mandatory).
Experience:
- Minimum one year of experience in Clinical Research is mandatory.
Walk-In Interview Schedule
Eligible candidates are invited to attend the selection process directly. Please note that if the number of candidates is high, an MCQ-based written test will be conducted to shortlist individuals for the interview.
| Detail | Information |
| Date of Interview | 20 February 2026 |
| Reporting Time | 10:00 AM to 11:00 AM |
| Venue | HRD Meeting Room, 3rd Floor, Main Building, Dr. E. Borges Marg, Parel, Tata Memorial Hospital, Mumbai – 400012 |
Documents Required for Interview
Candidates must carry the following documents (original + one set of attested photocopies):
- Bio-data (Updated CV).
- Recent Passport size Photograph.
- Identity Proof: PAN Card and AADHAAR Card.
- Academic Certificates: SSC, HSC, Graduation, and PG Diploma certificates/mark sheets.
- Experience Certificates: Documents proving at least one year of work in clinical research.
- NOC: Internal candidates must provide a No Objection Certificate from their current PI or HOD.
About the Research Projects
- Project 6975: A study on the combination of Bendamustine and fixed-dose Nivolumab for children with relapsed Hodgkin Lymphoma.
- Project 6847: A pivotal trial of Naxitamab (hu3F8) and GM-CSF for high-risk Neuroblastoma patients.
About the Author
